Candriam SCA’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5M | Buy |
719,513
+64,379
| +10% | +$2.37M | 0.15% | 128 |
|
|
2025
Q1 | $23.2M | Sell |
655,134
-1,606
| -0.2% | -$56.8K | 0.15% | 146 |
|
|
2024
Q4 | $28.7M | Buy |
656,740
+92,958
| +16% | +$4.07M | 0.17% | 125 |
|
|
2024
Q3 | $25.6M | Buy |
563,782
+9,448
| +2% | +$428K | 0.15% | 145 |
|
|
2024
Q2 | $21.5M | Sell |
554,334
-29,616
| -5% | -$1.15M | 0.13% | 157 |
|
|
2024
Q1 | $18.8M | Sell |
583,950
-23,000
| -4% | -$741K | 0.12% | 175 |
|
|
2023
Q4 | $17.4M | Buy |
606,950
+45,002
| +8% | +$1.29M | 0.12% | 176 |
|
|
2023
Q3 | $15.6M | Sell |
561,948
-18,000
| -3% | -$498K | 0.11% | 172 |
|
|
2023
Q2 | $15.5M | Sell |
579,948
-26,384
| -4% | -$706K | 0.11% | 192 |
|
|
2023
Q1 | $12.1M | Sell |
606,332
-126,173
| -17% | -$2.52M | 0.08% | 232 |
|
|
2022
Q4 | $17.4M | Hold |
732,505
| – | – | 0.12% | 189 |
|
|
2022
Q3 | $14.4M | Buy |
732,505
+177,250
| +32% | +$3.5M | 0.1% | 207 |
|
|
2022
Q2 | $10.8M | Buy |
555,255
+121,051
| +28% | +$2.36M | 0.09% | 215 |
|
|
2022
Q1 | $11.1M | Sell |
434,204
-16,178
| -4% | -$413K | 0.08% | 242 |
|
|
2021
Q4 | $11.3M | Sell |
450,382
-39,000
| -8% | -$982K | 0.07% | 246 |
|
|
2021
Q3 | $13.5M | Buy |
489,382
+95,312
| +24% | +$2.62M | 0.09% | 230 |
|
|
2021
Q2 | $12.5M | Buy |
394,070
+394,060
| +3,940,600% | +$12.5M | 0.09% | 257 |
|
|
2021
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 818 |
|